4d Molecular Therapeutics, Inc. (FDMT)

Last Three Months

29-Jan-24 -- 28-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

7

0

0

+1

0

+2

0

+3

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Feb-24 8:22 PM View:	08-Feb-24 Private Sale (Planned) ($2.50M)	Kirn David Chief Executive Officer Director		4d Molecular Therapeutics, Inc. - FDMT	(8%) 1.15M to 1.06M	0	0	--	--	Show Txns Hide Txns

07-Feb-24 8:32 PM View:	05-Feb-24 Sale (Planned) ($16.59K)	Kim Robert Young Chief Medical Officer		4d Molecular Therapeutics, Inc. - FDMT	(35%) 1.59K to 1.04K	0	0	--	--	Show Txns Hide Txns

18-Apr-24 8:48 PM View:	16-Apr-24 Planned Option Sale ($45.04K)	Bizily Scott Chief Legal Officer		4d Molecular Therapeutics, Inc. - FDMT	0% 1.74K	0	0	--	--	Show Txns Hide Txns